Suppr超能文献

相似文献

1
Genotype-phenotype correlation and molecular heterogeneity in pyruvate kinase deficiency.
Am J Hematol. 2020 May;95(5):472-482. doi: 10.1002/ajh.25753. Epub 2020 Mar 6.
2
Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study.
Blood. 2018 May 17;131(20):2183-2192. doi: 10.1182/blood-2017-10-810796. Epub 2018 Mar 16.
3
Six novel variants in the PKLR gene associated with pyruvate kinase deficiency in Argentinian patients.
Clin Biochem. 2021 May;91:26-30. doi: 10.1016/j.clinbiochem.2021.02.003. Epub 2021 Feb 23.
4
Identification and in silico characterization of a novel PKLR genotype in a Turkish newborn.
Mol Biol Rep. 2020 Oct;47(10):8311-8315. doi: 10.1007/s11033-020-05836-2. Epub 2020 Sep 24.
6
Red cell pyruvate kinase deficiency in Spain: A study of 15 cases.
Med Clin (Barc). 2017 Jan 6;148(1):23-27. doi: 10.1016/j.medcli.2016.10.004. Epub 2016 Nov 19.
8
A novel and a previously described compound heterozygous PKLR gene mutations causing pyruvate kinase deficiency in a Chinese child.
Fetal Pediatr Pathol. 2014 Jun;33(3):182-90. doi: 10.3109/15513815.2014.890260. Epub 2014 Mar 6.
9
Molecular and clinical heterogeneity in pyruvate kinase deficiency in India.
Blood Cells Mol Dis. 2013 Oct;51(3):133-7. doi: 10.1016/j.bcmd.2013.05.006. Epub 2013 Jun 14.

引用本文的文献

1
Efficacy and Safety of Mitapivat in Pyruvate Kinase Deficiency: A Systematic Review and Meta-analysis of Clinical Trials.
Indian J Hematol Blood Transfus. 2025 Jan;41(1):112-120. doi: 10.1007/s12288-024-01830-x. Epub 2024 Aug 6.
2
How We Treat Hemolytic Anemia Due to Pyruvate Kinase Deficiency.
Hematol Rep. 2024 Aug 31;16(3):559-567. doi: 10.3390/hematolrep16030054.
3
Reporting on Therapeutic Advancements Requires Accurate Language.
Am J Ther. 2025;32(1):e48-e49. doi: 10.1097/MJT.0000000000001787. Epub 2024 Jul 19.
4
Oxidative Stress in Healthy and Pathological Red Blood Cells.
Biomolecules. 2023 Aug 18;13(8):1262. doi: 10.3390/biom13081262.
6
Neonatal Thrombocytopenia as a Presenting Finding in de novo Pyruvate Kinase Deficiency.
Neonatology. 2023;120(5):661-665. doi: 10.1159/000531242. Epub 2023 Jul 20.
7
Clinical outcome and genotype analysis of four Chinese children with pyruvate kinase deficiency.
Mol Genet Genomic Med. 2023 Nov;11(11):e2239. doi: 10.1002/mgg3.2239. Epub 2023 Jul 19.
9
The Pyruvate Kinase Deficiency Global Longitudinal (Peak) Registry: rationale and study design.
BMJ Open. 2023 Mar 23;13(3):e063605. doi: 10.1136/bmjopen-2022-063605.
10
Updates and advances in pyruvate kinase deficiency.
Trends Mol Med. 2023 May;29(5):406-418. doi: 10.1016/j.molmed.2023.02.005. Epub 2023 Mar 17.

本文引用的文献

1
Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency.
N Engl J Med. 2019 Sep 5;381(10):933-944. doi: 10.1056/NEJMoa1902678.
2
Aberrant splicing contributes to severe α-spectrin-linked congenital hemolytic anemia.
J Clin Invest. 2019 Apr 30;129(7):2878-2887. doi: 10.1172/JCI127195.
4
How we manage patients with pyruvate kinase deficiency.
Br J Haematol. 2019 Mar;184(5):721-734. doi: 10.1111/bjh.15758. Epub 2019 Jan 25.
6
7
The burden of disease in pyruvate kinase deficiency: Patients' perception of the impact on health-related quality of life.
Eur J Haematol. 2018 Dec;101(6):758-765. doi: 10.1111/ejh.13128. Epub 2018 Sep 28.
8
Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study.
Blood. 2018 May 17;131(20):2183-2192. doi: 10.1182/blood-2017-10-810796. Epub 2018 Mar 16.
9
M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity.
Nat Genet. 2016 Dec;48(12):1581-1586. doi: 10.1038/ng.3703. Epub 2016 Oct 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验